Morning Overview on MSN
New AI tool aims to predict small cell lung cancer treatment response
Researchers have built an AI-powered pathology tool designed to predict whether small cell lung cancer patients will respond ...
NeoRad(Low): A phase 2 trial of neoadjuvant (NA) ipilimumab + nivolumab (ipi+nivo) with low dose stereotactic body radiation therapy (SBRT) as an immune stimulant in patients with resectable stage ...
Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results